Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Further re possible offer

10 Apr 2008 11:15

Braveheart Investment Group plc10 April 2008 Not for release, publication or distribution in whole or in part, in or into theUnited States, Canada, Australia, Japan or the Republic of Ireland Braveheart Investment Group plc ("Braveheart" or the "Company") Possible Offer Further to the announcement released by Braveheart on 9th April 2008, theCompany wishes to confirm the following revised dealing disclosure requirementsand Rule 2.10 information on Braveheart. Dealing Disclosure RequirementsUnder the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the"Code"), if any person is, or becomes, "interested" (directly or indirectly) in1 per cent. or more of any class of "relevant securities" of ANGLE orBraveheart, all "dealings" in any "relevant securities" of that company(including by means of an option in respect of, or a derivative referenced to,any such "relevant securities") must be publicly disclosed by no later than 3.30pm (London time) on the London business day following the date of the relevanttransaction. This requirement will continue until the date on which the offerbecomes, or is declared, unconditional as to acceptances, lapses or is otherwisewithdrawn or on which the "offer period" otherwise ends. If two or more personsact together pursuant to an agreement or understanding, whether formal orinformal, to acquire an "interest" in "relevant securities" of ANGLE orBraveheart, they will be deemed to be a single person for the purpose of Rule8.3. Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevantsecurities" of ANGLE or Braveheart, by ANGLE or Braveheart or by any of their"associates", must be disclosed by no later than 12.00 noon (London time) on theLondon business day following the date of the relevant transaction. A disclosuretable, giving details of the companies in whose "relevant securities" "dealings"should be disclosed, and the number of such securities in issue, can be found onthe Takeover Panel's website at www.thetakeoverpanel.org.uk. "Interests in securities" arise, in summary, when a person has long economicexposure, whether conditional or absolute, to changes in the price ofsecurities. In particular, a person will be treated as having an "interest" byvirtue of the ownership or control of securities, or by virtue of any option inrespect of, or derivative referenced to, securities. Terms in quotation marksare defined in the Code, which can also be found on the Panel's website. If youare in any doubt as to whether or not you are required to disclose a "dealing"under Rule 8, you should consult the Panel. Rule 2.10 RequirementIn accordance with Rule 2.10 of the City Code on Takeovers and Mergers,Braveheart Investment Group plc confirms that it currently has in issue13,403,895 ordinary shares of 2 pence each. The International SecuritiesIdentification Number for the ordinary shares is GB00B13XV322. For further information please contact: Noble & Company LimitedDavid Ovens, Director Tel: 0131 225 9677 Seymour Pierce Limited (nomad/broker to Braveheart)Jeremy Garrett-Cox, Director Tel: 020 7107 8000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th May 202012:48 pmRNSHolding(s) in Company
11th May 20208:51 amRNSHolding(s) in Company
11th May 20207:01 amRNSHolding(s) in Company
11th May 20207:00 amRNSHolding(s) in Company
7th May 20206:15 pmRNSHolding(s) in Company
6th May 20207:00 amRNSUpdate in response to social media speculation
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFurther re Kirkstall Limited
1st May 20207:00 amRNSFurther Placing to raise £350,000
29th Apr 20204:40 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
29th Apr 20207:00 amRNSPlacing to raise £275,000
27th Apr 202011:05 amRNSSecond Price Monitoring Extn
27th Apr 202011:00 amRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSOperational update re certain investments
14th Apr 20207:00 amRNSOperational update on the Strategic Investments
3rd Mar 20207:00 amRNSOperational Update and Strategic Investments
30th Jan 20207:00 amRNSOperational update on Strategic Investments
12th Dec 20197:00 amRNSFurther investment in Pharm 2 Farm Limited
21st Nov 20197:00 amRNSOperational update on strategic investments
31st Oct 201910:55 amRNSHalf-year Report
28th Oct 20195:12 pmRNSFurther re buying remaining shares of Paraytec
19th Sep 20197:00 amRNSResults of customer trials by Pharm2Farm Limited
18th Sep 20197:00 amRNSDiscussions to buy remaining shares of Paraytec
29th Aug 201912:20 pmRNSResult of AGM
5th Aug 20197:00 amRNSPosting of annual accounts
1st Aug 20193:27 pmRNSREPLACEMENT: Final Results
1st Aug 20197:00 amRNSFinal Results
8th Jul 20197:00 amRNSInvestment in Pharm2Farm Limited
7th Jun 20197:00 amRNSUpdate to the Market
16th Apr 20197:00 amRNSDisposal of Viking Fund Managers Limited
12th Feb 201910:25 amRNSHolding(s) in Company
31st Jan 20195:17 pmRNSHolding(s) in Company
13th Dec 20187:00 amRNSFund Management Division Update
30th Oct 20187:00 amRNSInterim Results
18th Oct 201811:28 amRNSUpdate re Reduction of Share Capital
24th Sep 20189:00 amRNSConversion of Loan Notes in Paraytec Limited
4th Sep 20187:00 amRNSFurther re. Partial Disposal of Investment
21st Aug 20187:00 amRNSPartial Disposal of Investment in Gyrometric
19th Jul 201812:15 pmRNSResult of AGM and GM
16th Jul 20187:00 amRNSUpdate on fund management business
12th Jul 20187:00 amRNSProposed funding round by Paraytec Limited
10th Jul 201810:44 amRNSHolding(s) in Company
25th Jun 20187:00 amRNSFurther re. Notice of Annual General Meeting
21st Jun 20185:16 pmRNSConfirmation of Posting
20th Jun 201810:30 amRNSAppointment of Joint Broker
18th Jun 20187:02 amRNSNotice of General Meeting
18th Jun 20187:00 amRNSFinal Results
26th Apr 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.